ClinicalTrials.gg
Sign In

Drug

Ombitasvir/Paritaprevir/Ritonavir clinical trials

studies test it
15
open now
0
in phase 3
10
first study started
2013

How studies write it

Studies that test it under each name

Name

ombitasvir/paritaprevir/ritonavir
13
ombitasvir also known as ABT-267
5
paritaprevir also known as ABT-450
5
ABT-267 also known as ombitasvir
2
ABT-450 also known as paritaprevir
2

Combined with it in one product

PTV/r/OBV/DSV
1
Viekirax/Exviera
1

Studies by the year they started

15 studies that test it; most in 2015 (5)

Studies that test Ombitasvir/Paritaprevir/Ritonavir, by start year
YearStudies
20131
20144
20155
20161
20173
20181

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
3
Phase 3
10
Phase 4
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Hepatitis C, Chronic
11
Hepatitis C
1
Hepatitis
1
Coinfection
1

Who runs them

Industry 11 · Other 4

AbbVie (11) · Assiut University (2) · Beni-Suef University (1) · National Taiwan University Hospital (1)

Often tested with

Tested in the same studies.

Dasabuvir (10) · Ribavirin (7) · Ritonavir (4) · Ombitasvir (3) · Paritaprevir (3) · Dasabuvir sodium monohydrate (1) · Simeprevir (1) · Daclatasvir (1)

Studies

Open first, then newest update. How each study uses Ombitasvir/Paritaprevir/Ritonavir is read from its arms, and is right about nine times in ten.

Testing it · 15

Given in every arm · 2 — Ombitasvir/Paritaprevir/Ritonavir is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Ombitasvir/Paritaprevir/Ritonavir